Kazakhstan

Abdi İbrahim founded Abdi İbrahim Global Pharm (AİGP) in 2012, after acquiring a 60 percent stake in Global Pharm, one of the leading pharmaceutical producers in Kazakhstan. Standing out as the most modern GMP production facility in Kazakhstan, AİGP commenced operations in late 2015 with an annual production capacity of 24 million units, marking the first overseas production of Abdi İbrahim. With a facility extending over 12,000 square meters of indoor area, AİGP contributes to Abdi İbrahim’s goal of becoming a strong international brand with its extensive portfolio of around 100 products, including mainly diabetes and antiviral products, as well as central nervous system and cardiovascular agents. The headquarters of AİGP is located in Almaty, the financial hub of Kazakhstan, where the company engages in the production and sale of a broad spectrum of pharmaceutical products.

The main goals of AİGP are to support the pharmaceutical industry of Kazakhstan, introduce innovative new medicines in the country, and achieve market leadership in exports to CIS countries by establishing multi-dimensional marketing operations.

AİGP’s portfolio of around 100 products is mainly focused on antibacterial/antiviral medicines, cardiology, dermatology, endocrine and metabolism, gastroenterology, neurology, NSAI and myorelaxant and respiratory agents as well as vitamins & minerals.

• Employees 200
• Products 50
• Production Facilities 1
• Production Capacity 24 Million Units / Year

Azerbaijan

Since 2004, Abdi İbrahim has been conducting sales and marketing teams assigned to five regions, namely Ganjha, Salian, Barda, Shumgaid and Baku.

Abdi İbrahim’s activities in Azerbaijan are focused on the areas of cardiology, dermatology, neurology and respiratory medicine, and products manufactured in the company’s Istanbul production complex are delivered to patients in Azerbaijan.

• Employees 20
• Products 23

Albania

Abdi İbrahim commenced its activities in Albania in 2010 by establishing its local sales and marketing organization. All products marketed in Albania are produced in the Istanbul production complex.

Abdi İbrahim’s operations in Albania are focused on respiratory and central nervous system, as well as pain management, OTC and other specialized fields of medicine.

• Employees 9
• Products 25

Bosnia and Herzegovina

Abdi İbrahim commenced its operations in Bosnia and Herzegovina in 2015 by establishing its local sales and marketing organization. All products marketed in Bosnia and Herzegovina are produced in the Istanbul production complex. The company’s product range is focused mainly on pain, central nervous system and respiratory medicine.

• Employees Over 13
• Products 16

Algeria

Abdi İbrahim founded Abdi İbrahim Remede Pharma (AİRP) in Algeria in 2014 as a joint venture with Remede Pharma. In the same year, the company began investing in the most modern pharmaceutical production facility in the country. AİRP commenced operations in 2017 with an annual production capacity of 51 million units. Abdi İbrahim produces and markets products covering a wide range of therapeutic areas by joining forces with Remede Pharma, a move that forms part of the company’s international partnership drive that carries the purpose of positioning Abdi İbrahim as a strong, international brand.

AİRP’s product portfolio includes cancer and diabetes medicine, antipsychotics and antidepressants, urology and respiratory agents and iron supplements.

• Employees Over 300
• Products 30
• Production Facilities 1
• Production Capacity 51 Million Units / Year

Georgia

Abdi İbrahim conducts sales and marketing activities in Georgia with a representation office established in 2007 as well as local sales & marketing teams in two regions, namely Kutaisi and Tbilisi.

Abdi İbrahim’s operations in Georgia are focused on the area of psychiatry, cardiology, neurology and respiratory medicine. All products marketed in Georgia are produced in the Istanbul production complex.

• Employees 10
• Products 26

Tunisia

Abdi İbrahim commenced its operations in Tunisia in 2011 by establishing its local sales and marketing organization. All products marketed in Tunisia are produced in the Istanbul production complex.

Abdi İbrahim’s product range in Tunisia is focused on central nervous system and respiratory medicine.

• Employees 11
• Products 4

Iraq

Abdi İbrahim commenced its operations in Iraq in 2011 by establishing its local sales and marketing organization. Abdi İbrahim’s product range in Iraq consists of cardiology, respiratory and central nervous system, OTC and hepatology.

All products marketed in Iraq are produced in the Istanbul production complex.

• Employees 60
• Products 25